For Protection Against liver Disease Some Omega-3 Oils Better than Others
Author: Linus Pauling Institute
Synopsis and Key Points:
Research has discovered a particular omega-3 has a more powerful effect in preventing liver inflammation and fibrosis than other fatty acids.
Main DigestResearch at Oregon State University has found that one particular omega-3 fatty acid has a powerful effect in preventing liver inflammation and fibrosis - common problems that are steadily rising along with the number of Americans who are overweight.
Omega 3 - A polyunsaturated fatty acid whose carbon chain has its first double valence bond three carbons from the beginning. Omega-3 fatty acids are considered essential fatty acids and are necessary for human health but the body can' t make them. Sources of Omega-3 fatty acids can be found in fish, such as salmon, tuna, and halibut, other seafood including algae and krill, some plants, and nut oils.
The American Liver Foundation has estimated that about 25 percent of the nation's population, and 75 percent of those who are obese, have nonalcoholic fatty liver disease. This early-stage health condition can sometimes progress to more serious, even fatal diseases, including nonalcoholic steatohepatitis, or NASH, as well as cirrhosis and liver cancer.
The study, published online in the Journal of Nutrition, was one of the first to directly compare the effects of two of the Omega 3 fatty acids often cited for their nutritional value, DHA and EPA.
In research with laboratory animals, it found that EPA had comparatively little effect on preventing the fibrosis, or scarring, that's associated with NASH. However, DHA supplementation reduced the proteins involved in liver fibrosis by more than 65 percent.
"A reduction of that magnitude in the actual scarring and damage to the liver is very important," said Donald Jump, a principal investigator with the Linus Pauling Institute at OSU and a professor in the College of Public Health and Human Sciences.
"Many clinical trials are being done with omega-3 fatty acids related to liver disease," Jump said. "Our studies may represent the first to specifically compare the capacity of EPA versus DHA to prevent NASH. It appears that DHA, which can also be converted to EPA in the human body, is one of the most valuable for this purpose."
The issues have taken center stage as the weight of Americans continues to rise, with a related increase in the incidence of fatty liver disease and liver damage.
NASH is a progressive form of liver disease that is associated with chronic inflammation and oxidative stress, resulting from excess fat storage in the liver. Chronic inflammation can eventually lead to fibrosis, cirrhosis, or even liver cancer. While management of lifestyle, including weight loss and exercise, is one approach to control the onset and progression of fatty liver disease, other approaches are needed to prevent and treat it.
About 30-40 percent of people with nonalcoholic fatty liver disease progress to NASH, which in turn can result in cirrhosis, a major risk factor for liver cancer. While this research studied the prevention of fatty liver disease, Jump said, ongoing studies are examining the capacity of DHA to be used in NASH therapy.
The levels of omega-3 oils needed vary with the health concern, officials say.
"Omega-3 fatty acids are typically recommended for the prevention of cardiovascular disease," Jump said. "Recommended intake levels of omega-3 fatty acids in humans for disease prevention are around 200-500 milligrams of combined DHA and EPA per day."
Levels used in therapy to lower blood triglycerides, also a risk factor for cardiovascular disease, are higher, about 2-4 grams of combined EPA and DHA per day. The OSU studies with mice used DHA at levels comparable to the triglyceride therapies.
"DHA was more effective than EPA at attenuating inflammation, oxidative stress, fibrosis and hepatic damage," the researchers wrote in their conclusion. "Based on these results, DHA may be a more attractive dietary supplement than EPA for the prevention and potential treatment of NASH in obese humans."
This work was the result of a four-year study supported by the USDA National Institute of Food and Agriculture, as well as the National Institutes of Health. Co-authors on the paper included Christopher M. Depner and Kenneth A. Philbrick, both graduate students in the Nutrition Graduate Program at OSU.
About the Linus Pauling Institute - The Linus Pauling Institute at OSU is a world leader in the study of micronutrients and their role in promoting optimum health or preventing and treating disease. Major areas of research include heart disease, cancer, aging and neurodegenerative disease.
The grants supporting this research included grant number 2009-65200-05846 from the USDA National Institute of Food and Agriculture, and grant numbers 43220 and 094600 from the National Institutes of Health.
- 1 - Is Genetically Modified Soybean Oil Healthy? : University of California - Riverside (2015/03/09)
- 2 - Including Canola Oil in Diet May Cut Belly Fat : Victoria M. Indivero - Pennsylvania State University (2016/11/02)
- 3 - Status of Fish Oil with Regards to Purity : Dr. Dave's Best (2010/04/02)
- 4 - Delaying Fat Digestion to Curb Appetite : Norwich BioScience Institutes (2010/08/19)
- 5 - High Omega-6 Fatty Acid Levels Can Protect Against Premature Death : University of Eastern Finland (2018/04/01)
- 6 - Omega-3 from Fish Better Than from Flax for Cancer Prevention : University of Guelph (2018/01/27)
- 7 - Eat Fat and Live Longer - High Fat Diet Increases Longevity and Strength : University of California - Davis (2017/09/14)
• Disabled World is strictly a news and information website provided for general informational purpose only and does not constitute medical advice. Materials presented are in no way meant to be a substitute for professional medical care by a qualified practitioner, nor should they be construed as such. Any 3rd party offering or advertising on disabled-world.com does not constitute endorsement by Disabled World.